The FDA, which had stated it would make a final decision on the Rx-to-OTC switch of Barr's Plan B by September, has postponed a decision for another 60 days.
Maker Barr Pharmaceuticals criticized the decision, questioning how the agency could agree that scientific evidence backed nonprescription sales and yet not allow those sales to begin.I guess they're waiting for the Repubevangelical counterpart to Sharia law to be implemented here.
Tags: health care; contraception; abortion; reproductive rights; fundamentalism; FDASphere: Related Content
No comments:
Post a Comment